The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

A Quest for Evidence

Posted by Brian Overstreet on February 12, 2016


This week marks the sixth anniversary of the date that Bob Kyle, Henry Duong, and I incorporated Advera Health Analytics.  We started this journey with a mission to improve patient outcomes by making drug safety data more accessible and actionable.  We spent the early years developing our technologies, building our data delivery platform, and subjecting our early methodologies to peer review.  Two years ago we began to commercialize our enterprise data product and since then we’ve grown exponentially.

Read More

Topics: Clinical Trials, Hepatitis C, Clinical Evidence, Real World Evidence, Evidence

Drug Safety Perspectives on Hepatitis C

Posted by Dr. Keith Hoffman on February 27, 2015

 

In the past two weeks AdverseEvents has been invited to share our drug safety analytics and insight on two different panel discussions focused on the new hepatitis C medications. Two things really struck me about this.

Read More

Topics: Hepatitis C

Did Express Scripts Choose the Right Hepatitis C Drug?

Posted by Jim Davis on January 16, 2015


Last week’s blog post discussed the dangerous precedent that exclusivity deals between drug manufacturers and payers set. Deals like the one Express Scripts and AbbVie’s signed for discounted rates on the new Hepatitis C drug, Viekira Pak. I argued that these deals emphasize the payer trend of focusing on immediate savings rather than overall outcomes, total cost of care and most importantly patient safety.

It’s becoming clear that my argument was right.

Read More

Topics: Express Scripts, Hepatitis C, Sovaldi (sofosbuvir)

Hepatitis C: why side effects of treatment are a particularly big deal

Posted by Dr. Keith Hoffman on June 12, 2014


Hepatitis is a fancy word for liver inflammation. Sounds just somewhat serious, right?

Wrong, infections that cause Hepatitis can be a very grim business. In fact, they are responsible for one of the world’s largest healthcare burdens.

Hepatitis can be caused by different viral infections that are designated by the astonishingly creative nomenclature of A, B, C, D, and E. Hepatitis C (HCV) is what we will focus on today. ~200 million people carry this virus around inside them, including 3-4 million Americans. Ten times as many people are infected with HCV than HIV.  It is the most common blood-borne viral infection in the world and is responsible for substantial amounts of morbidity and death.

Read More

Topics: Hepatitis C, HCV, treatment, side effects, Sovaldi (sofosbuvir)

Subscribe to Email Updates